Mutations in the cohesin complex in acute myeloid leukemia: clinical and prognostic implications
- 6 February 2014
- journal article
- research article
- Published by American Society of Hematology in Blood
- Vol. 123 (6), 914-920
- https://doi.org/10.1182/blood-2013-07-518746
Abstract
Key Points Mutations in genes of the cohesin complex are recurrent mutations in AML with a strong association with NPM1 mutations. Cohesin gene mutations have no clear prognostic impact in AML patients.Keywords
This publication has 38 references indexed in Scilit:
- Genomic and Epigenomic Landscapes of Adult De Novo Acute Myeloid LeukemiaNew England Journal of Medicine, 2013
- Sister chromatid segregation in meiosis II: Deprotection through phosphorylationCell Cycle, 2013
- Cohesin, a chromatin engagement ringCurrent Opinion in Cell Biology, 2013
- Translational mechanisms at work in the cohesinopathiesNucleus, 2012
- The Origin and Evolution of Mutations in Acute Myeloid LeukemiaCell, 2012
- Incidence and Prognostic Influence of DNMT3A Mutations in Acute Myeloid LeukemiaJournal of Clinical Oncology, 2011
- Mutations and Treatment Outcome in Cytogenetically Normal Acute Myeloid LeukemiaNew England Journal of Medicine, 2008
- Chromatid cohesion defects may underlie chromosome instability in human colorectal cancersProceedings of the National Academy of Sciences, 2008
- Cohesin mediates transcriptional insulation by CCCTC-binding factorNature, 2008
- Risk-adapted induction and consolidation therapy in adults with de novo AML aged ≤ 60 years: results of a prospective multicenter trialAnnals of Hematology, 2004